(4S)-4-Ethyl-4-[[2-[4-[[[(5R,5aR,8aR,9R)-5,5a,6,8,8a,9-hexahydro-8-oxo-9-(3,4,5-trimethoxyphenyl)furo[3?,4?:6,7]naphtho[2,3-d]-1,3-dioxol-5-yl]oxy]carbonyl]phenoxy]acetyl]oxy]-3,4,12,14-tetrahydro-3,14-dioxo-1H-pyrano[3?,4?:6,7]indolizino[1,2-b]quinolin-9-yl [1,4?-bipiperidine]-1?-carboxylate
Advanced Cancer
Neovia Oncology Ltd.Small moleculePhase 1Dormant
CC
42/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 32/ 100
- Competitive Position
- 73/ 100
Competitive context
1412 Active assets in the Advanced Cancer cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
Nabiximols Jazz Pharmaceuticals | Phase 3 | BBB |
Inno-206 M.D. Anderson Cancer Center | Phase 2 | BB |
Vitamin B6 M.D. Anderson Cancer Center | Phase 4 | BB |
PROPOFOL Hong Kong Children's Hospital | Phase 4 | BB |
Rivoceranib Jiangsu HengRui Medicine Co., Ltd. | Phase 4 | BB |
View all 50 →
Same molecule, other indications
(4S)-4-Ethyl-4-[[2-[4-[[[(5R,5aR,8aR,9R)-5,5a,6,8,8a,9-hexahydro-8-oxo-9-(3,4,5-trimethoxyphenyl)furo[3?,4?:6,7]naphtho[2,3-d]-1,3-dioxol-5-yl]oxy]carbonyl]phenoxy]acetyl]oxy]-3,4,12,14-tetrahydro-3,14-dioxo-1H-pyrano[3?,4?:6,7]indolizino[1,2-b]quinolin-9-yl [1,4?-bipiperidine]-1?-carboxylate is also rated in:
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →